Navigation Links
CfPIE Provides Regulatory Affairs Recertification (RAC) Points Recognized by the Regulatory Affairs Professionals Society (RAPS)
Date:12/18/2013

Malvern, PA (PRWEB) December 18, 2013

The Center for Professional Innovation and Education (CfPIE)—a global provider of life sciences technical training—is now a Regulatory Affairs Professionals Society (RAPS) RA Professional Development Portal provider. CfPIE specializes in FDA regulatory compliance training and now awards Regulatory Affairs Recertification (RAC) points through a large selection of pharmaceutical, biotechnology, and medical device courses.

“We are committed to providing quality education to allow regulatory professionals worldwide to stay in-the-know and enhance skills, while supporting career advancement opportunities,” says Mark Mazzie, CfPIE founder and Managing Director. “More than half of our classroom courses count for up to 12 RAC points to help individuals quickly earn their professional development credits.”

CfPIE’s Course Directors are highly-experienced, industry-active and hold senior-level scientific, regulatory and management positions in the life sciences industry. They offer a comprehensive knowledge base that goes into every course they provide. Class sizes are limited to 20 attendees, ensuring an engaging learning environment.

A selection of regulatory-specific courses within CfPIE’s comprehensive curriculum includes:

Adverse Drug Events: Reporting & Regulatory Requirements. This course will provide part
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CfPIE Announces Advisory Board to Support Continued Life Sciences Training Alignment with Industry Regulations
2. New CfPIE Website Highlights Life Science Training Options for the Latest FDA Guidances and Standards
3. CfPIE’s Newest Training Course Facilitates Life Science Professionals in Staying Current with FDA Approval Trends
4. Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update
5. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
6. Advanced light source provides a new look at vanadium dioxide
7. Epizyme, Inc. Provides Third Quarter 2013 Financial Results and Corporate Update
8. New Book Provides Industry Guidance for Major Pharmaceutical Firms
9. Organovo Reports Q1 Fiscal 2014 Results, Provides Business Update
10. Fast Linear Positioning Stage with Voice Coil Drive Provides 270 mm/sec, 0.1 Micron Resolution, by PI (Physik Instrumente)
11. Compact Linear Piezo Nanopositioning Stage Provides 1 Inch Travel, Nanometer Closed-Loop Resolution, Introduced by PI miCos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Launched by the ... in December 2011, ,SARAH, - the French ... versus sorafenib in advanced hepatocellular carcinoma (HCC) has enrolled ... SARAH, a large French study of patients ... HCC) has completed patient enrolment, exceeding its 400-patient target, ...
(Date:3/3/2015)... SAN DIEGO , March 3, 2015  Halozyme Therapeutics, ... the Barclays 2015 Global Healthcare Conference in Miami, ... ET/10:05 a.m. PT. David A. Ramsay , Chief Financial ... will be webcast through the "Investors" section of Halozyme,s corporate ... made available for 90 days following the event. To access ...
(Date:3/3/2015)... and Markets ( http://www.researchandmarkets.com/research/rcv4lq/gene_therapy ) has announced ... - 2025" report to their offering. ... extensive study on the marketed and pipeline gene therapies. ... this field for over a decade but there are ... one approved in the EU). There are many promising ...
(Date:3/3/2015)... 03, 2015 BlueInGreen ... their international sales network. The business venture will ... to Canada’s Atlantic Provinces, exclusively through Resource Systems. ... one of Canada’s premiere manufacturing representative firms, hosting ... municipal water and wastewater markets. More information on ...
Breaking Biology Technology:Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7BlueInGreen® Continues Canadian Expansion, Partners with Resource Systems Inc. 2
... June 12 Biopure Corporation,(Nasdaq: BPUR ) announced ... an additional 180 days, or until December 8, 2008, ... bid price,of $1.00 for continued listing. Currently, the Company ... Market. If, at any time,before December 8, 2008, the ...
... Chindex International,Inc. (Nasdaq: CHDX ), an independent ... products in the People,s,Republic of China, provided the ... which will be reported in the Company,s Annual ... the Securities and Exchange Commission,on Monday, June 16, ...
... XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) ... Meeting and Extraordinary General,Meeting (collectively, the "Meetings") scheduled for ... record at the close of business on,June 12, 2008 ... the Meetings. All,shareholders are cordially invited to attend the ...
Cached Biology Technology:Biopure Granted Additional 180 Day Compliance Period by NASDAQ 2Chindex International, Inc. Quantifies Fourth Quarter Charges 2Chindex International, Inc. Quantifies Fourth Quarter Charges 3Notification of Record Date for the Annual General Meeting and Extraordinary General Meeting 2
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 28, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... present at the upcoming RedChip Global Online CEO Conference ... Gino Pereira , CEO of ... discussing its lead product, the Wocket smart wallet and ...
(Date:1/22/2015)... CHICAGO , Jan. 9, 2015 Valid S.A. ("Company") ... the market in general the State of Washington,s ... contract for a new enrollment and central issuance system for ... The project planning and development will start ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... handful of very special mice, scientists have discovered a ... implicated in the development of human leukemia, findings that ... study authors say. , Researchers in The Ohio State ... that develops acute lymphoblastic leukemia (ALL). The mouse first ...
... good handle on how to teach human cells to do ... mouth's lining to form bone. , But in the real ... bone of a person undergoing radiation therapy for cancer means ... well as compensating for the damage of radiation. , "It's ...
... involving the buzzword "nano" - cancer detection using nanoparticles ... of cancers is one of the most important parts ... prognosis and determination,of the most appropriate treatment. And an ... not there has been lymphatic spread. Current,methods include surgical ...
Cached Biology News:Genome-wide mouse study yields link to human leukemia 2Genome-wide mouse study yields link to human leukemia 3U-M scientist to talk about tissue engineering at AAAS 2Imaging Lymph Nodes with Nanoparticles 2
Anti-HumanLactoferrin...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
ICAD Purified Anti-Mouse clone Polyclonal, Isotype Rabbit Ig, 200 µl Consult technical datasheet for details....
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: